Trial Profile
[18F]Fluciclovine and [18F]FLT PET/CT Assessment of Primary High-Grade Brain Tumors
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 22 Mar 2024
Price :
$35
*
At a glance
- Drugs Fluciclovine 18F (Primary)
- Indications Brain cancer
- Focus Diagnostic use
- 18 Mar 2024 Status changed from recruiting to discontinued.
- 06 Dec 2023 Planned End Date changed from 1 Nov 2023 to 15 Sep 2024.
- 06 Oct 2022 Planned End Date changed from 1 Nov 2022 to 1 Nov 2023.